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Editorial
Cholera and ABO Blood Group: Understanding an Ancient Association
Jason B. Harris1,2* and Regina C. LaRocque1,3
1Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts; 2Department of Pediatrics, Harvard Medical School,
Boston, Massachusetts; 3Department of Medicine, Harvard Medical School, Boston, Massachusetts
Since the association was first recognized by Barua and
Paguio in 1977,1 many investigators have confirmed a strong
link between cholera and the human blood group O pheno-
type. Although the blood type O does not affect the risk
of being infected with Vibrio cholerae, it has a tremendous
impact on disease severity.2 For example, when cholera was
introduced into Peru in 1991, individuals with blood type O
were eight times more likely to be hospitalized with severe
cholera.3 Thus, for individuals infected with V. cholerae,
blood type can be a life or death matter.
It is also very likely that the association between severe
cholera and blood type O has impacted our evolutionary his-
tory. The lowest prevalence of the O blood group phenotype
in the world is in the Ganges delta, where cholera has likely
been endemic for centuries.4 This suggests that cholera has
left a genetic imprint in historically endemic areas, and
means that as cholera spreads to areas with a higher preva-
lence of the blood type O, the proportion of individuals with
severe forms of cholera will be higher.
In this issue of the American Journal of Tropical Medicine
and Hygiene, F. Matthew Kuhlmann and others at Washington
University take a step forward toward understanding the
mechanism of the association between blood group and chol-
era severity.5 The authors studied the effect of cholera toxin
on enteroids—a cell culture model derived from ileal and
colonic stem cells that differentiate in vitro into tissue that
mimics many features of the intestinal surface. Using this
approach, the team compared the responses of cholera
toxin-stimulated enteroids derived from blood type O donors
to responses of identically stimulated enteroids from blood
group A donors. The investigators demonstrated a signifi-
cantly greater cyclic adenosine monophosphate response to
cholera toxin in enteroids derived from blood type O stem
cells. The team then demonstrated a similar effect after
converting a blood type A-derived cell line to a blood type
O phenotypic cell, using clustered regularly interspaced short
palindromic repeats technology to alter the gene that con-
trols glycosylation of the ABO blood group glycans.
Taken together, these results provide very convincing evi-
dence that cholera toxin exerts a more potent effect on cells
expressing the blood type O-associated glycan. This fits with
the epidemiologic observation that blood type O only impacts
disease severity, but not the risk of infection. However, this
work still does not identify the precise mechanism by which
cholera toxin induces a stronger response in the type O cells.
In fact, a surprising finding in this study was that the greater
effect of cholera toxin in blood group O-derived cells did
not appear to be linked to the amount of toxin binding to
cells, which was similar in both the type A- and type O-
derived cells.
The Kuhlmann study coincides with interesting work
recently published by Heggelund and others, who reported
the first high-resolution crystal structure of cholera toxin bound
to the A and O blood group glycans.6 Although Heggelund and
others did not evaluate the cellular response to cholera toxin,
the authors demonstrated that the toxin binds to the blood
group O determinant in multiple orientations and with greater
affinity than it binds to the blood group A determinants.
What makes this story even more intriguing is that the
ABO blood group determinant is not the primary receptor
for cholera toxin. Instead, the cellular response to cholera
toxin is derived from the high-affinity binding of the toxin to
the cognate GM1 ganglioside receptor. Thus, it is not clear
how the affinity and orientation of binding to the ABO-
related blood antigens impacts the cellular response to chol-
era toxin. Perhaps a final step in tying this together at a
mechanistic level will be understanding how variations in the
ABO blood group glycans impact the interaction between
cholera toxin and the GM1 ganglioside. For example, this
could be dependent on toxin binding, but could also be
dependent on specific cell surface interactions between
GM1 ganglioside and the ABO blood group glycans. Thus,
it seems likely that there is still more to learn. Hopefully, an
improved understanding of the molecular mechanisms of
this long-observed genetic predisposition to this ancient dis-
ease will lead to new approaches for combating this globally
important pathogen.
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